21 results

e66 Prognostic value of post-treatment 18F-fluorodeoxyglucose positron emission tomography in uterine cervical cancer patients treated with radiotherapy: a systematic review and meta-analysis
Yeon Joo Kim, Sangwon Han, Young Seok Kim, Joo-Hyun Nam
J Gynecol Oncol. 2019;30(5):e66.  Published online 2019 March 11    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e66
e67 Involved-field radiation therapy for selected cases of recurrent ovarian cancer
Nalee Kim, Jee Suk Chang, Sang Wun Kim, Gun Min Kim, Jung-Yun Lee, Yong Bae Kim
J Gynecol Oncol. 2019;30(5):e67.  Published online 2019 March 15    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e67
e70 Improved preoperative risk stratification with CA-125 in low-grade endometrial cancer: a multicenter prospective cohort study
Casper Reijnen, Nicole CM Visser, Jenneke C Kasius, Dorry Boll, Peggy M Geomini, Huy Ngo, Dennis van Hamont, Brenda M Pijlman, Maria Caroline Vos, Johan Bulten, Marc PLM Snijders, Leon FAG Massuger, Johanna MA Pijnenborg
J Gynecol Oncol. 2019;30(5):e70.  Published online 2019 March 14    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e70
e72 Prior uterine myoma and risk of ovarian cancer: a population-based case-control study
Jenn-Jhy Tseng, Chun-Che Huang, Hsiu-Yin Chiang, Yi-Huei Chen, Ching-Heng Lin
J Gynecol Oncol. 2019;30(5):e72.  Published online 2019 March 20    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e72
e74 Transperitoneal para-aortic lymphadenectomy by robot assisted laparoscopy in 10 steps
Mellie Heinemann, Isabelle Masquin, Guillaume Blache, Laura Sabiani, Camille Jauffret, Gilles Houvenaeghel, Eric Lambaudie
J Gynecol Oncol. 2019;30(5):e74.  Published online 2019 March 29    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e74
e75 Overexpression of HER2/HER3 and clinical feature of ovarian cancer
Ye Won Chung, Seongmin Kim, Jin Hwa Hong, Jae Kwan Lee, Nak Woo Lee, Young Seok Lee, Jae Yun Song
J Gynecol Oncol. 2019;30(5):e75.  Published online 2019 March 25    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e75
e76 Evaluation of satisfaction with three different cervical cancer screening modalities: clinician-collected Pap test vs. HPV test by self-sampling vs. HPV test by urine sampling
Hye Young Shin, Bomyee Lee, Sang-Hyun Hwang, Dong Ock Lee, Na Young Sung, Jae Young Park, Jae Kwan Jun
J Gynecol Oncol. 2019;30(5):e76.  Published online 2019 March 19    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e76
e77 Pseudolaric acid B inhibits PAX2 expression through Wnt signaling and induces BAX expression, therefore promoting apoptosis in HeLa cervical cancer cells
Defeng Guan, Chenyang Li, Xiao Lv, Yongxiu Yang
J Gynecol Oncol. 2019;30(5):e77.  Published online 2019 March 29    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e77
e78 The efficacy of modified Swede Colposcopic Index in prediction of high-grade lesion and cancer of cervix
Nopporn Rodpenpear, Kamol Pataradool
J Gynecol Oncol. 2019;30(5):e78.  Published online 2019 April 2    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e78
e81 Treatment strategies for patients with advanced ovarian cancer undergoing neoadjuvant chemotherapy: interval debulking surgery or additional chemotherapy?
Yutaka Yoneoka, Mitsuya Ishikawa, Takashi Uehara, Hanako Shimizu, Masaya Uno, Takashi Murakami, Tomoyasu Kato
J Gynecol Oncol. 2019;30(5):e81.  Published online 2019 March 29    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e81
e84 Lymph-vascular space invasion (LVSI) as a strong and independent predictor for non-locoregional recurrences in endometrial cancer: a Danish Gynecological Cancer Group Study
Gitte Ørtoft, Lisa Lausten-Thomsen, Claus Høgdall, Estrid S Hansen, Margit Dueholm
J Gynecol Oncol. 2019;30(5):e84.  Published online 2019 May 16    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e84
e86 PARAGON (ANZGOG-0903): a phase 2 study of anastrozole in asymptomatic patients with estrogen and progesterone receptor-positive recurrent ovarian cancer and CA125 progression
Peey-Sei Kok, Philip Beale, Rachel L. O'Connell, Peter Grant, Tony Bonaventura, James Scurry, Yoland Antill, Jeffrey Goh, Katrin Sjoquist, Anna DeFazio, Cristina Mapagu, Frederic Amant, Michael Friedlander,
J Gynecol Oncol. 2019;30(5):e86.  Published online 2019 April 30    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e86
e92 Preoperative CA-125 in low-grade endometrial cancer: risk stratification and implications for treatment
Janice S. Kwon
J Gynecol Oncol. 2019;30(5):e92.  Published online 2019 May 16    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e92
e98 Aromatase inhibition in ovarian cancer: repeated signals of efficacy but tools for patient selection remain elusive
Charlie Gourley
J Gynecol Oncol. 2019;30(5):e98.  Published online 2019 July 5    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e98
e101 Erratum: Bowel resection rate but not bowel related morbidity is decreased after interval debulking surgery compared to primary surgery in patents with stage IIIC–IV ovarian cancer
Roberto Tozzi, Jvan Casarin, Ahmet Baysal, Gaetano Valenti, Yakup Kilic, Hooman Soleymani Majd, Matteo Morotti
J Gynecol Oncol. 2019;30(5):e101.  Published online 2019 June 3    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e101
e104 Minimally invasive surgery for radical hysterectomy in women with cervical cancer: Korean Society of Gynecologic Oncology, Korean Society of Obstetrics and Gynecology, and Korean Society of Gynecologic Endoscopy and Minimally Invasive Surgery position statement
Miseon Kim, Tae-Wook Kong, Sunghoon Kim, Seung Cheol Kim, Yong Beom Kim, Jae-Weon Kim, Jeong-Yeol Park, Dong Hoon Suh, Seung-Hyuk Shim, Keun Ho Lee, Sung Jong Lee, Jae-Kwan Lee, Myong Cheol Lim
J Gynecol Oncol. 2019;30(5):e104.  Published online 2019 July 16    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e104
e105 How to use immune checkpoint inhibitor in ovarian cancer?
Junsik Park, Jung-Yun Lee, Sunghoon Kim
J Gynecol Oncol. 2019;30(5):e105.  Published online 2019 June 24    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e105
e106 Letter to editor in response to: prior uterine myoma and risk of ovarian cancer: a population-based case-control study
Samuel George Oxley, Fusun Sirkeci, Funlayo Odejinmi
J Gynecol Oncol. 2019;30(5):e106.  Published online 2019 June 27    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e106
e107 ASCO 2019 meeting review
Elisabeth Diver, Oliver Dorigo, Jonathan Berek
J Gynecol Oncol. 2019;30(5):e107.  Published online 2019 July 9    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e107
e108 After the Laparoscopic Approach to Cervical Cancer (LACC) trial: Korean Society of Gynecologic Oncology (KSGO) survey
Miseon Kim, Yong Beom Kim, Jae-Weon Kim
J Gynecol Oncol. 2019;30(5):e108.  Published online 2019 July 10    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e108
e109 Response to comment on: prior uterine myoma and risk of ovarian cancer: a population-based case-control study
Chun-Che Huang, Ching-Heng Lin
J Gynecol Oncol. 2019;30(5):e109.  Published online 2019 July 10    DOI: http://dx.doi.org/10.3802/jgo.2019.30.e109
Articles from Journal of Gynecologic Oncology are provided here courtesy of Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology